Related Experiment Videos
In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivatives
J Dubois1, R Arnould, F Abikhalil
1Unité de Toxicologie et de Chimie Bioanalytique, Université Libre de Bruxelles, Belgium.
Abstract:
The cytotoxicity of hexamethylmelamine (HMM) and its metabolites was investigated in three murine cell lines: one in vitro naturally sensitive to HMM (RC) and two in vivo naturally resistant (P388 and P388D1). The percentage of viable cells was determined both by the in situ reduction of a tetrazolium salt (MTT assay) and by the uptake of labelled thymidine into DNA (3HTdR assay). Short (1h) and long (48h) exposures of cells to drugs were considered. In all experimental conditions used, HMM was found to be inactive, whereas its hydroxylated metabolite hydroxymethylpentamethylmelamine (HMPMM) and one analog N, N 'dihydroxymethyltetramethylmelamine (DHTMM) were found to be cytotoxic. The results further indicated that HMM must be metabolized before it can exert its cytotoxic effect. The activity of HMPMM and DHTMM was found unlikely to be related to extracellular or intracellular release of formaldehyde.
Insights
Hexamethylmelamine (HMM) requires metabolic activation to become cytotoxic. Its metabolites, hydroxymethylpentamethylmelamine (HMPMM) and N,N′-dihydroxymethyltetramethylmelamine (DHTMM), demonstrated significant cell-killing activity in murine cell lines.
Area of Science:
- Pharmacology
- Toxicology
- Cancer Research
Background:
- Hexamethylmelamine (HMM) is an antineoplastic agent.
- Understanding the cytotoxic mechanisms of HMM and its metabolites is crucial for optimizing cancer therapy.
- Investigating drug resistance in cancer cell lines provides insights into treatment efficacy.
Purpose of the Study:
- To evaluate the cytotoxicity of hexamethylmelamine (HMM) and its metabolites.
- To compare the activity of HMM and its metabolites in HMM-sensitive and HMM-resistant murine cell lines.
- To elucidate the metabolic requirements for HMM's cytotoxic effects.
Main Methods:
- Cytotoxicity assays including MTT and 3HTdR uptake were performed on three murine cell lines (RC, P388, P388D1).
- Cells were exposed to HMM and its metabolites under short (1h) and long (48h) incubation periods.
- Comparative analysis of drug activity in vitro and in vivo naturally sensitive and resistant cell lines.
Main Results:
- Hexamethylmelamine (HMM) itself exhibited no cytotoxic activity across all tested conditions.
- Hydroxymethylpentamethylmelamine (HMPMM) and N,N′-dihydroxymethyltetramethylmelamine (DHTMM) were identified as the primary cytotoxic metabolites of HMM.
- The cytotoxic effects of HMPMM and DHTMM were independent of formaldehyde release.
Conclusions:
- HMM must undergo metabolic transformation to exert its cytotoxic effects.
- The metabolites HMPMM and DHTMM are responsible for the observed cytotoxicity of HMM.
- These findings highlight the importance of metabolic activation in HMM's anticancer activity and provide a basis for further drug development.